299 related articles for article (PubMed ID: 30864529)
1. Recent Development in Indole Derivatives as Anticancer Agents for Breast Cancer.
Kaur K; Jaitak V
Anticancer Agents Med Chem; 2019; 19(8):962-983. PubMed ID: 30864529
[TBL] [Abstract][Full Text] [Related]
2. Recent Development in Indole Derivatives as Anticancer Agent: A Mechanistic Approach.
Devi N; Kaur K; Biharee A; Jaitak V
Anticancer Agents Med Chem; 2021; 21(14):1802-1824. PubMed ID: 33397272
[TBL] [Abstract][Full Text] [Related]
3. Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review.
Sidhu JS; Singla R; Mayank ; Jaitak V
Anticancer Agents Med Chem; 2015; 16(2):160-73. PubMed ID: 25991424
[TBL] [Abstract][Full Text] [Related]
4. Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
Arya GC; Kaur K; Jaitak V
Eur J Med Chem; 2021 Oct; 221():113511. PubMed ID: 34000484
[TBL] [Abstract][Full Text] [Related]
5. Bestowal of Quinazoline Scaffold in Anticancer Drug Discovery.
Das R; Mehta DK; Dhanawat M
Anticancer Agents Med Chem; 2021; 21(11):1350-1368. PubMed ID: 32593282
[TBL] [Abstract][Full Text] [Related]
6. Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies.
Sahil ; Kaur K; Jaitak V
Curr Med Chem; 2022 Aug; 29(29):4958-5009. PubMed ID: 35306982
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, and
Choudhari RC; Kaur K; Das A; Jaitak V
Curr Comput Aided Drug Des; 2024; 20(5):640-652. PubMed ID: 37888813
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
9. The anti-breast cancer potential of indole/isatin hybrids.
Wang R; Huang R; Yuan Y; Wang Z; Shen K
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300402. PubMed ID: 37650315
[TBL] [Abstract][Full Text] [Related]
10. The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor.
Sarwar M; Syed Khaja AS; Aleskandarany M; Karlsson R; Althobiti M; Ødum N; Mongan NP; Dizeyi N; Johnson H; Green AR; Ellis IO; Rakha EA; Persson JL
Oncogene; 2019 Jan; 38(3):375-389. PubMed ID: 30104711
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and apoptotic effects of indole derivative, N-(2-hydroxy-5-nitrophenyl (4'-methylphenyl) methyl) indoline in breast cancer cells.
Palanivel S; Murugesan A; Subramanian K; Yli-Harja O; Kandhavelu M
Eur J Pharmacol; 2020 Aug; 881():173195. PubMed ID: 32446710
[TBL] [Abstract][Full Text] [Related]
12. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity.
Jia Y; Wen X; Gong Y; Wang X
Eur J Med Chem; 2020 Aug; 200():112359. PubMed ID: 32531682
[TBL] [Abstract][Full Text] [Related]
13. PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials.
Dey N; De P; Leyland-Jones B
Pharmacol Ther; 2017 Jul; 175():91-106. PubMed ID: 28216025
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiproliferative and pro-apoptotic activity of 2-phenylindoles.
Kelly PM; Bright SA; Fayne D; Pollock JK; Zisterer DM; Williams DC; Meegan MJ
Bioorg Med Chem; 2016 Sep; 24(18):4075-4099. PubMed ID: 27407030
[TBL] [Abstract][Full Text] [Related]
15. A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer.
Naeem M; Iqbal MO; Khan H; Ahmed MM; Farooq M; Aadil MM; Jamaludin MI; Hazafa A; Tsai WC
Molecules; 2022 May; 27(11):. PubMed ID: 35684353
[TBL] [Abstract][Full Text] [Related]
16. Indole compounds against breast cancer: recent developments.
Biersack B; Schobert R
Curr Drug Targets; 2012 Dec; 13(14):1705-19. PubMed ID: 23140282
[TBL] [Abstract][Full Text] [Related]
17. New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors.
La Regina G; Bai R; Coluccia A; Naccarato V; Famiglini V; Nalli M; Masci D; Verrico A; Rovella P; Mazzoccoli C; Da Pozzo E; Cavallini C; Martini C; Vultaggio S; Dondio G; Varasi M; Mercurio C; Hamel E; Lavia P; Silvestri R
Eur J Med Chem; 2018 May; 152():283-297. PubMed ID: 29730191
[TBL] [Abstract][Full Text] [Related]
18. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells.
Kamal A; Lakshma Nayak V; Nagesh N; Vishnuvardhan MV; Subba Reddy NV
Bioorg Chem; 2016 Jun; 66():124-31. PubMed ID: 27149364
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors.
Kazan F; Yagci ZB; Bai R; Ozkirimli E; Hamel E; Ozkirimli S
Comput Biol Chem; 2019 Jun; 80():512-523. PubMed ID: 31185422
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral activity of indole-3-carbinol cyclic tri- and tetrameric derivatives mixture in human breast cancer cells: in vitro and in vivo studies.
Brandi G; Fraternale A; Lucarini S; Paiardini M; De Santi M; Cervasi B; Paoletti MF; Galluzzi L; Duranti A; Magnani M
Anticancer Agents Med Chem; 2013 May; 13(4):654-62. PubMed ID: 23092288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
